Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 34 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Plain-language summary

All non-differential bias scenarios were biased toward the null (Table 1). In most differential scenarios, we could not say that observed differences in ADRD diagnosis were different by Appalachian County designation (Figures 1-2). However, if the sensitivity of ADRD diagnosis was more than 10-20% lower in Appalachian counties, the true prevalence difference for Appalachian compared to non-Appalachian counties ranged from 1.3% (95% SI: 0.1%, 2.2%) to 2.8% (0.2%, 4.8%) and the true prevalence ratio ranged from 1.14 (1.06, 1.17) to 1.35 (1.12, 1.63). Using claims to estimate ADRD prevalence is imperfect. We found that if ADRD diagnostic sensitivity is lower in under-resourced areas, the disparity between under-resourced and resourced regions may be substantially underestimated.

What this study adds

Evidence grade: Low

This study found that if Alzheimer's diagnosis is less sensitive in under-resourced Appalachian counties, the true difference in prevalence between Appalachian and non-Appalachian counties may be underestimated. Reported effect size: 1.3%; 0.1%; 2.2%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Wing, J. J., Rajczyk, J. I., Strominger, J., & Burke, J. F. (2025). Impact of outcome misclassification in Medicare claims on geographic differences in ADRD prevalence in Central Appalachia. Alzheimer s & Dementia. https://doi.org/10.1002/alz70860_104910

Vancouver

Wing JJ, Rajczyk JI, Strominger J, Burke JF. Impact of outcome misclassification in Medicare claims on geographic differences in ADRD prevalence in Central Appalachia. Alzheimer s & Dementia. 2025. doi:10.1002/alz70860_104910. PMID: 41434871.

BibTeX

@article{wing2025-41434871,
  author  = {Wing, Jeffrey J. and Rajczyk, Jenna I. and Strominger, Julie and Burke, James Francis},
  title   = {{Impact of outcome misclassification in Medicare claims on geographic differences in ADRD prevalence in Central Appalachia}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70860_104910},
  pmid    = {41434871},
  url     = {https://doi.org/10.1002/alz70860_104910}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that if Alzheimer's diagnosis is less sensitive in under-resourced Appalachian counties, the true difference in prevalence between Appalachian and non-Appalachian counties may be underestimated. It is about how disease rates are measured, not about treating, curing, or preventing Alzheimer's disease.

Study details

How this study scored 34/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 34 of 100.34 of 100 points earned66 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author James Francis Burke: h-index 61 (OpenAlex, whole career)
Institution's track record 1 / 3 The Ohio State University: institution h-index 1,378 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41434871)
Free to read 2 / 2 Free to read
Total 34 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Risk factors from nearby years

Also in Risk factors

356 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.

Similar studies

More on Risk factors

See all studies in Risk factors →